12 Cathie Wood Verve Therapeutics Trades
Cathie Wood acquired 6.04 Million Verve Therapeutics shares worth $37.2 Million. That's 0.30% of their equity portfolio (51st largest holding). The investor owns 7.15% of the outstanding Verve Therapeutics stock. Cathie Wood started to build up the position in Verve Therapeutics in Q2 2021 and continued to invest until Q4 2023. Since then they sold 985 Thousand shares. The investor's estimated purchase price is $164 Million, resulting in a loss of 77%.
News about Verve Therapeutics Inc and Cathie Wood
Inside Cathie Wood’s Portfolio: 3 Stocks She Is Betting Millions On
Cathie Wood, the brilliant mind behind ARK Invest , is known for her unique ability to spot disruptive trends in stocks. Her investment strategies have made ...
Verve: Spiffy Biotech That Cathie Wood Bought, Initiating With A Hold Rating (NASDAQ:VERV)
Verve Therapeutics is developing a CRISPR-based gene therapy for cardiovascular diseases. Click here for our take on VERN assets and stock prospects.